NMRA
Neumora Therapeutics Inc.
$1.86
-$0.03(-1.85%)
54
Overall
60
Value
83
Tech
21
Quality
Market Cap
$301.22M
Volume
270.86K
52W Range
$0.61 - $17.19
Target Price
$7.00
EPS Estimates Overview
| Current Quarter | $-0.34 | Next Quarter | $-0.35 |
| Current Year | $-1.43 | Next Year | $-1.08 |
| QoQ Growth | -2.9% | YoY Growth | +24.5% |
| 3Y EPS CAGR | N/A | Target Price | $7.00 |
| Consensus | Buy | Upside | +277.4% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NMRA | $1.86 | -1.9% | 270.86K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neumora Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW